Finally, they suggested that miR-21-5p may target PDHA1 to control a metabolic shift and cancer progression in gastric cancer, suggesting a possible function for this pathway in the therapy of gastric cancer (Hong and Park, 2014). The gene discussed is PDHA1; the disease is cancer.